A cost-effectiveness analysis of PHiD-CV compared to PCV13 in a national immunization program setting in Tunisia

Authors: Youness Lagoubi, Mohamed Tahar Sfar, Jorge A. Gomez

Source: Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)

Subject Terms: streptococcus pneumoniae, pneumococcal conjugate vaccine, 10-valent pneumococcal non-typeable haemophilus influenzae protein d conjugate vaccine, 13-valent pneumococcal conjugate vaccine, pcv10, pcv13, cost-effectiveness, tunisia, invasive pneumococcal disease, acute otitis media, phid-cv, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

Access URL: https://doaj.org/article/cddce0097de54bbb90675bec9de910c3

This result is not displayed to guests.
Login for full access.